Phase 4 Heart Disease Trial, Recruiting (NCT07472959)

Phase 4 Heart Disease Trial, Recruiting NCT07472959 Sponsor: Istanbul University - Cerrahpasa Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07472959 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 80 years of age
People classified as ASA III, meaning they have a serious but stable ongoing medical condition (confirm with trial site)
People who are already scheduled for a planned (non-emergency) coronary artery bypass grafting (heart bypass) operation

Who may not be able to join:

People who regularly use opioid pain medicines on an ongoing basis
People with severe liver or kidney disease
People with a history of alcohol or drug abuse
People whose heart pumps less than 40% of its blood with each beat (a measure of how well the heart is working)
People who are unable to be taken off a breathing machine within 12 hours after the operation is completed
People who are having additional heart surgery at the same time, such as a heart valve procedure
People who need a device called an intra-aortic balloon pump to help support their heart
People whose surgery is performed on a beating heart (rather than using a heart-lung bypass machine)
People who require emergency surgery
People who need to return to surgery because of bleeding or other complications
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +905369256721

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07472959

Sponsor: Istanbul University - Cerrahpasa

Phase: Phase 4

Status: Recruiting

Condition: Heart Disease

Trial contact: +905369256721

More information: https://clinicaltrials.gov/study/NCT07472959

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 80 years of age
People classified as ASA III, meaning they have a serious but stable ongoing medical condition (confirm with trial site)
People who are already scheduled for a planned (non-emergency) coronary artery bypass grafting (heart bypass) operation

Who may not be able to join:

People who regularly use opioid pain medicines on an ongoing basis
People with severe liver or kidney disease
People with a history of alcohol or drug abuse
People whose heart pumps less than 40% of its blood with each beat (a measure of how well the heart is working)
People who are unable to be taken off a breathing machine within 12 hours after the operation is completed
People who are having additional heart surgery at the same time, such as a heart valve procedure
People who need a device called an intra-aortic balloon pump to help support their heart
People whose surgery is performed on a beating heart (rather than using a heart-lung bypass machine)
People who require emergency surgery
People who need to return to surgery because of bleeding or other complications
People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Istanbul University - Cerrahpasa

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

1 May 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

VAS Level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov